Avanos Medical (AVNS) Shares Outstanding (Weighted Average) (2013 - 2026)

Avanos Medical's Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $46.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 0.87% year-over-year to $46.5 million; the TTM figure through Mar 2026 stood at $46.5 million (up 0.87% YoY), while the FY2025 annual figure was $46.3 million, up 0.65% from the prior year.
• Shares Outstanding (Weighted Average) came in at $46.5 million for Q1 2026 at Avanos Medical, roughly flat from $46.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $47.4 million in Q1 2022 to a low of $45.9 million in Q2 2024.
• A 5-year average of $46.5 million and a median of $46.5 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) decreased 3.12% in 2022 and increased 0.87% in 2025, its largest moves.
• Avanos Medical's Shares Outstanding (Weighted Average) stood at $46.9 million in 2022, then retreated by 0.64% to $46.6 million in 2023, then fell by 1.29% to $46.0 million in 2024, then rose by 0.65% to $46.3 million in 2025, then climbed by 0.43% to $46.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $46.5 million, $46.3 million, and $46.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison